Author(s): Ahmed K, Safdar K, Kemmer N, Atiq M, Wang J,
Abstract Share this page
Abstract Recent World Health Organization (WHO) reports estimate that 500-600 million people worldwide are at risk of schistosomiasis. In areas of high prevalence of hepatitis C (HCV) and schistosomiasis there is an increased risk for end-stage liver disease. Liver transplant is a viable option for those with HCV or other liver pathology and schistosomiasis. Posttransplant recurrence of schistosomiasis has rarely been described. We report a case of posttransplant recurrence of schistosomiasis.
This article was published in Transplant Proc
and referenced in Journal of Transplantation Technologies & Research